precision pharmacy semaglutide Semaglutide 5mg — Selective GLP-1

Mounjaro (Tirzepatide) Dual action: targets both GLP-1 and GIP receptors Strong appetite suppression & improved blood sugar control Clinical trials show average body weight loss up to 22.5% over 72 weeks Wegovy (Semaglutide) Targets GLP-1 receptors only Licensed in the UK for obesity and cardiovascular protection STEP trials show 1521% body weight loss A new 7.2mg dose is expected in late 2025, with results potentially matching Mounjaro Both treatments are once-weekly injections, prescribed alongside healthy diet and lifestyle changes

iu ny khin GLP-1RA tr thnh la chn linh hot v t ri ro hn cho nhng bnh nhn khng mun hoc khng th s dng cc thuc gim cn khc

Still, the findings suggest the need for patient-tailored decisions to maximize the benefits and minimize harms and overuse of treatments, they concluded.

This included the GLP-1 (7-37) peptide

The American Society of Anesthesiologists previously advised many patients to stop weekly GLP-1 medications before surgery